THE EFFECTIVENESS OF TRIPLE-DOSE ALBENDAZOLE IN COMPARISON WITH MEBENDAZOLE FOR THE TREATMENT OF TRICHURIASIS IN CHILDREN

Authors

  • SALEHA SUNGKAR Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • FANNY P. IRMAWATI Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • ROSE A. HASWINZKY Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • YASMINE A. DWINASTITI Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • SRI WAHDINI Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia,
  • NURHADI E. FIRMANSYAH Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • ROBIATUL ADAWIYAH Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
  • STANLEY BUNTARAN Jakarta Medical Center Hospital, Jakarta, Indonesia
  • ARIA KEKALIH Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • GLADYS KUSUMOWIDAGDO Department of Parasitology Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

DOI:

https://doi.org/10.22159/ijap.2019.v11s6.33559

Keywords:

Trichuriasis, Albendazole, Mebendazole, Cure rate, Egg reduction rate

Abstract

Objective: Trichuriasis is difficult to treat with single-dose anthelmintic. Although a higher cure rate (CR) can be achieved by treatment with triple-dose albendazole and mebendazole, the results of studies are inconsistent. This study aimed to evaluate the effectiveness of triple-dose albendazole and mebendazole in treating trichuriasis.

Methods: A randomized controlled trial was conducted in a primary school in the Pandeglang District, Banten Province, Indonesia in July–August, 2018; 382 children were recruited. Stools were collected and examined microscopically using the Kato–Katz method to identify Trichuriasis eggs. Children positive for Trichuris trichiura were randomized and divided into two groups. One was given a triple dose of 400 mg albendazole and the other a triple dose of 500 mg mebendazole. On day 14 after treatment, stools were reexamined to calculate CR and the egg reduction rate (ERR). Data were analyzed using SPSS version 20.

Results: The prevalence of soil-transmitted helminth infection was 42%, and that of trichuriasis and ascariasis was 25.1% and 29.8%. There was a significant difference (Wilcoxon test, P<0.01) in the intensity of infection before and after intervention. Both groups showed high values of CR (mebendazole: 95.2%, albendazole: 85.4%; Fisher’s exact test, P = 0.125) and ERR (mebendazole: 99%, albendazole: 96%; Mann–Whitney test, P = 0.110). There was no significant difference in CR and ERR between the two groups.

Conclusion: Triple-dose albendazole was as effective as triple-dose mebendazole in treating trichuriasis.

Downloads

Download data is not yet available.

References

1. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006;367:1521-32.
2. Woodhall D, Jones JL, Cantey PT, Wilkins PP, Montgomery SP. Neglected parasitic infections: what every family physician needs to know. Am Fam Physician 2014;89:803-11.
3. Sungkar S, Pohan A, Ramadani A, Albar N, Azizah F, Nugraha A, et al. Heavy burden of intestinal parasite infections in Kalena Rongo village, a rural area in South West Sumba, eastern part of Indonesia: a cross sectional study. BMC Public Health 2015;15:1296.
4. Sungkar S, Sianturi I, Kusumowidagdo G. Human Infection with Hymenolepis spp: case reports from east Indonesia. Arch Parasitol 2017;1:1.
5. WHO. Preventive chemotherapy in human helminthiasis. Geneva: WHO; 2006.
6. WHO. Soil-transmitted helminth infections; 2017. Available from: http://www.who.int/mediacentre/factsheets/fs366/en/. [Last accessed on 10 Nov 2018]
7. Steinmann P, Utzinger J, Du Z, Jiang J, Chen J, Hattendorf, et al. Efficacy of single-dose and triple-dose albendazole and mebendazole against STH and Taenia spp: a randomized controlled trial. PLoS One 2011:6:1-8.
8. Sungkar S, Asri S Ridwan, Kusumowidagdo G. The effect of deworming using triple-dose albendazole on nutritional status of children in perobatang village, Southwest Sumba, Indonesia. J Parasitol Res 2017. https://doi.org/10.1155/2017/5476739
9. Mulambalah CS, Ruto J. Prevalence and infection intensity of geohelminthiases on school children as an environmental health indicator to guide preventive activities in Nandi County, Kenya. Trop J Med Res 2016;19:131-7.
10. Khanum H, Mukutmoni M, Uddin J, Haque R. Diarrheal carriage illness with Trichuris trichiura among the slum dwelling children in Dhaka city. Biores Comm 2016;2:254-8.
11. Legesee M, Erko B, Medhin G. Comparative efficacy of albendazole and three brands of mebendazole in the treatment of ascariasis and trichuriasis. East Afr Med J 2004;81:134-8.
12. Knopp S, Mohammed KA, Speich B, Hattendorf J, Khamis IS, Khamis NA, et al. Albendazole and mebendazole administered alone or in combination with ivermectin against T. trichiura: a randomized controlled trial. Clin Infect Dis 2010;51:1420-8.
13. Moser W, Schindler W, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. Br Med J 2017;358:j4307.
14. Simeon D, Callender J, Wong M, Grantham-McGregor S, Ramdath DD. School performance, nutritional status and trichuriasis in Jamaican school children. Acta Pediatrica 1994;83:1188-93.
15. Kaminsky RG, Castillo RV, Flores CA. Growth retardation and severe anemia in children with Trichuris dysenteric syndrome. Asian Pac J Trop Biomed 2015;5:591-7.

Published

15-12-2019

How to Cite

SUNGKAR, S., IRMAWATI, F. P., HASWINZKY, R. A., DWINASTITI, Y. A., WAHDINI, S., FIRMANSYAH, N. E., ADAWIYAH, R., BUNTARAN, S., KEKALIH, A., & KUSUMOWIDAGDO, G. (2019). THE EFFECTIVENESS OF TRIPLE-DOSE ALBENDAZOLE IN COMPARISON WITH MEBENDAZOLE FOR THE TREATMENT OF TRICHURIASIS IN CHILDREN. International Journal of Applied Pharmaceutics, 11(6), 104–107. https://doi.org/10.22159/ijap.2019.v11s6.33559

Issue

Section

Original Article(s)